Latest news
25 items- PRPetIQ Names Camillo Pane as Chief Executive OfficerAccomplished Consumer Goods and Health Care LeaderWould Bring Decades of Leadership Experience to Role EAGLE, Idaho, Feb. 11, 2025 (GLOBE NEWSWIRE) -- PetIQ, Inc. ("PetIQ" or the "Company"), a leading pet medication, health and wellness company and portfolio company of Bansk Group, is pleased to announce that Camillo Pane would join PetIQ as Chief Executive Officer, effective February 17, 2025. Mr. Pane would succeed Cord Christensen. Mr. Pane's passion for making a difference in the lives of consumers has been a constant focus throughout his more than 30-year career. His drive and commitment in this area has led to strong share gains and profitable growth at a variety of iconic consumer
- 13D/GAmendment: SEC Form SC 13G/A filed by PetIQ Inc.SC 13G/A - PetIQ, Inc. (0001668673) (Subject)
- 13D/GAmendment: SEC Form SC 13G/A filed by PetIQ Inc.SC 13G/A - PetIQ, Inc. (0001668673) (Subject)
- SECSEC Form 15-12G filed by PetIQ Inc.15-12G - PetIQ, Inc. (0001668673) (Filer)
- 13D/GAmendment: SEC Form SC 13G/A filed by PetIQ Inc.SC 13G/A - PetIQ, Inc. (0001668673) (Subject)
- 13D/GAmendment: SEC Form SC 13G/A filed by PetIQ Inc.SC 13G/A - PetIQ, Inc. (0001668673) (Subject)
- INSIDERChief Financial Officer Glasman Zvi returned 25,800 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - PetIQ, Inc. (0001668673) (Issuer)
- INSIDERDirector Huff Scott returned 6,077 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - PetIQ, Inc. (0001668673) (Issuer)
- INSIDEREVP Manufacturing & Sup. Chain Lyon Chad D. returned 10,659 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - PetIQ, Inc. (0001668673) (Issuer)
- INSIDEREVP, GENERAL COUNSEL Carter William J. returned 3,497 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - PetIQ, Inc. (0001668673) (Issuer)
- INSIDERDirector First Mark L returned 1,991,234 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - PetIQ, Inc. (0001668673) (Issuer)
- INSIDERDirector Oloughlin Sheryl returned 14,822 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - PetIQ, Inc. (0001668673) (Issuer)
- INSIDERPRESIDENT & COO Smith Michael A returned 88,808 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - PetIQ, Inc. (0001668673) (Issuer)
- INSIDERChief Executive Officer Christensen Mccord converted options into 114,027 shares and returned 259,702 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - PetIQ, Inc. (0001668673) (Issuer)
- INSIDERDirector Lefko Kimberly returned 14,822 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - PetIQ, Inc. (0001668673) (Issuer)
- INSIDERDirector Walker Kenneth C. returned 13,363 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - PetIQ, Inc. (0001668673) (Issuer)
- INSIDEREVP, SERVICES & MANUFACTURED Pearson John Paul returned 8,269 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - PetIQ, Inc. (0001668673) (Issuer)
- INSIDERDirector Hall Allan returned 12,807 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - PetIQ, Inc. (0001668673) (Issuer)
- SECSEC Form S-8 POS filed by PetIQ Inc.S-8 POS - PetIQ, Inc. (0001668673) (Filer)
- SECSEC Form S-8 POS filed by PetIQ Inc.S-8 POS - PetIQ, Inc. (0001668673) (Filer)
- SECSEC Form S-8 POS filed by PetIQ Inc.S-8 POS - PetIQ, Inc. (0001668673) (Filer)
- SECSEC Form 25-NSE filed by PetIQ Inc.25-NSE - PetIQ, Inc. (0001668673) (Subject)
- SECSEC Form S-8 POS filed by PetIQ Inc.S-8 POS - PetIQ, Inc. (0001668673) (Filer)
- SECPetIQ Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits8-K - PetIQ, Inc. (0001668673) (Filer)
- PRPetIQ, Inc. Announces Successful Completion of Acquisition by Bansk GroupEAGLE, Idaho and NEW YORK, Oct. 25, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. ("PetIQ" or the "Company") (NASDAQ:PETQ), a leading pet medication, health and wellness company, today announced the successful completion of its acquisition by Bansk Group ("Bansk"), a consumer-focused private investment firm dedicated to building distinctive consumer brands, in an all-cash transaction valued at approximately $1.5 billion. PetIQ stockholders will receive $31.00 in cash per PetIQ share in accordance with the terms of the transaction. With the completion of the transaction, PetIQ shares no longer trade on and will be delisted from the Nasdaq stock exchange. PetIQ is now a privately held company and co
PETQ FAQ
7 questionsWhat does PetIQ Inc. do?
PetIQ, Inc. operates as a pet medication and wellness company. It operates in two segments, Products and Services. The company offers Rx pet medications, which include heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and co-develops and manufactures its own proprietary value-branded products, as well as distributes third-party branded medications. It also provides OTC medications and supplies primarily within the flea and tick control, and behavior management categories of the health and wellness industry in various...Where does PETQ stock trade?
PetIQ Inc. (PETQ) is listed on NASDAQ.What sector and industry is PETQ in?
PetIQ Inc. operates in the Health Care sector, Other Pharmaceuticals industry.When did PetIQ Inc. go public?
PetIQ Inc. (PETQ) completed its IPO in 2017.What are analysts saying about PETQ?
PetIQ Inc. has had 8 recent analyst actions on file. The most recent action was from Truist: Hold with a $3100.00 price target on 2024-08-08. Recent price targets range from $2200.00 to $3200.00.What companies are similar to PETQ?
Notable peers in the same industry include MCK (McKesson Corporation), COR (Cencora Inc.), CAH (Cardinal Health Inc.), ABC (AmerisourceBergen Corporation), CVET (Covetrus Inc.). Compare PETQ side-by-side with any of them on Quantisnow.How can I track PETQ on Quantisnow?
Quantisnow aggregates PetIQ Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow PETQ to receive live email and push alerts on every new disclosure.